
CPT Code | Description |
---|---|
81225 | Cyp2c19 Gene Analysis Common Variants |
81226 | Cyp2d6 Gene Analysis Common Variants |
81227 | Cyp2c9 Gene Analysis Common Variants |
81355 | Vkorc1 Gene Analysis Common Variant(S) |
81401 | Molecular Pathology Procedure Level 2 A4/A5 |
81401 | Molecular Pathology Procedure Level 2 A4/A4 |
81479 | Unlisted Molelcular Pathology Procedure |
81350 | Ugt1a1 Gene Analysis Common Variants |
81400 | Molecular Pathology Procedure Level 1 |
81400 | Molecular Pathology Procedure Level 1 |
81479 | DPYD |
81231 | Molecular Pathology Procedure Level 2 A4/A5 |
81230 | Molecular Pathology Procedure Level 2 A4/A4 |
81232 | DPYD |
81328 | SLCO1B1 |
CDR Labs offers a comprehensive pharmacogenomics panel to help identify mutations that may affect a person’s metabolism and/or response to medications. Using a simple cheek swab and our 34 gene panel, our team identifies mutations that may affect a person’s drug metabolism and/or response to medications. Our pharmacists then review the patient’s current medications and the pharmacogenetic data to detect drug-to-drug and drug-to gene interactions. The report also includes a Medication Summary, a list of medications with evidence for the use of pharmacogenetic information, organized by their associated conditions. Medications are also organized based on drug-gene interactions. In this manner, Physicians can consider the information contained in the Medication Report before making any clinical or therapeutic decisions. Each report also includes an annotated guide to how to use and interpret the report.
Genes Included in the Panel
- ABCB1
- ABCC2
- ABCG2
- CYP1A1
- CYP1A2
- CYP2A6
- CYP2B6
- CYP2C19
- CYP2C8
- CYP2C9
- CYP2D6
- CYP2E1
- CYP3A4
- CYP3A5
- DPYD
- GSTP1
- NAT1
- NAT2
- SLC15A2
- SLC22A1
- SLC22A2
- SLC22A6
- SLCO1B1
- SLCO1B3
- SLCO2B1
- TPMT
- UGT1A1
- UGT2B15
- UGT2B7
- VKORC1